• 제목/요약/키워드: colon

검색결과 2,157건 처리시간 0.027초

Intestinal Bacterial ${\beta}-Glucuronidase$ Activity of Patients with Colon Cancer

  • Kim, Dong-Hyun;Jin, Young-Ho
    • Archives of Pharmacal Research
    • /
    • 제24권6호
    • /
    • pp.564-567
    • /
    • 2001
  • The fecal ${\beta}-glucuronidase$ activity of patients with colon cancer and healthy controls were measured to determine the relationship between the fluctuation of intestinal bacterial ${\beta}-glucuronidase$ and colon cancer. The fecal ${\beta}-glucuronidase$ activity of patients with colon cancer was 1.7 times higher than that of the healthy controls. However, when these fecal specimens were sonicated, the enzyme activity of patients with colon cancer was 12.1 times higher than that of the healthy controls. The fecal ${\beta}-glucuronidase$ activity of human Intestinal bacteria was drastically induced by its substrate or the bile secreted after a subcutaneous injection of 1,2-dimethylhydrazine (DMH) and benzo[a]pyrene into rats. DMH-and benzo[a]pyrene-treated biles induced ${\beta}-glucuronidase$ activity in the human intestinal microflora by approximately 1.5- and 2.3-fold, respectively. They also induced ${\beta}-glucuronidase$ in E. coli HGU-3, which is a ${\beta}-glucuronidase$-producing bacterium from the human intestine. D-saccharic acid 1,4-lactone similarly inhibited fecal ${\beta}-glucuronidase$ in several patients with colon cancer in addition to the healthy controls. This suggests that potent ${\beta}-glucuronidase$ activity is a prime factor in the etiology of colon cancer.

  • PDF

톳 에탄올 추출물에 의한 HT29 결장암 세포의 ROS 의존적 세포사멸 유도 (Induction of ROS-dependent apoptosis by ethanol extract of Hizikia fusiforme in HT29 colon carcinoma cells)

  • 홍수현;최영현
    • 한국해양바이오학회지
    • /
    • 제14권2호
    • /
    • pp.93-101
    • /
    • 2022
  • Hizikia fusiforme, a type of brown algae, is widely used in Asian cuisine. It has been reported to have various pharmacological effects. In this study, the effects of the ethanol extract from H. fusiforme (EAHF) on the proliferation of human colon carcinoma cells were investigated. The effect on the survival of human hepatocarcinoma and colon carcinoma cells was examined, and results revealed that the anti-proliferative effects of EAHF were higher in colon carcinoma cells than in hepatocarcinoma cells. The inhibition of proliferation of HT29 colon carcinoma cells by EAHF treatment was closely related to the induction of apoptosis. EAHF treatment also increased caspase activity and poly(ADP-ribose) polymerase degradation, induced mitochondrial dysfunction, altered Bcl-2 family protein expression, and increased the rate of cytochrome c released from the mitochondria into the cytoplasm. Furthermore, the production of reactive oxygen species (ROS) was markedly stimulated by EAHF treatment, and when ROS production was blocked, EAHF-induced cytotoxicity was significantly attenuated. These results indicate that the anticancer activity of EAHF in HT29 colon carcinoma cells was induced by ROS-dependent mitochondrial impairment. While EAHF exhibited potent anticancer activity in colon carcinoma cells in this study, further studies on the active components of EAHF and their efficacy should be performed.

대장암 검진-50세 이하부터 시작하는 것은 필요한 것인가? (Colon Cancer Screening-Is It Necessary to Start under the Age of 50?)

  • 신종범
    • Journal of Digestive Cancer Research
    • /
    • 제11권3호
    • /
    • pp.141-146
    • /
    • 2023
  • Colorectal cancer is the third most common cancer worldwide. The occurrence of colon cancer can be prevented by removing precursor lesions. Several countries are making efforts to prevent the occurrence of colon cancer via screening programs. Korea is also following suite by screening individuals < 50 years of age. Currently, the incidence of colon cancer among the young is increasing globally, and Korea has a high colon cancer incidence rate among individuals in their 20s and 40s. Therefore, it may be necessary to start the screening individuals < 50 years of age to detect the cancer's manifestation early. Moreover, advanced adenomas associated with poor prognosis can be detected early, the overall screening rate can be increased, and death from colon cancer at a young age can be prevented. Although the period of colorectal cancer screening has been expanded, the overall colorectal cancer screening rate has not. Additionally, increasing the screening rate among individuals > 50 years could reduce the mortality rate at a lower cost. Although the incidence of colon cancer is increasing in younger individuals, the evidence to conclude that screening at the age of < 50 years has a meaningful impact on the incidence and survival rates of colon cancer remains insufficient. Therefore, rather than following the trend and performing screening early, an approach that actively selects cases where tests for colorectal cancer diagnosis are required is warranted.

Two Cases of Robot-Assisted Totally Minimally Invasive Esophagectomy with Colon Interposition for Gastroesophageal Junction Cancer: Surgical Considerations

  • Kinam Shin;In Ha Kim;Yun-Ho Jeon;Chung Sik Gong;Chan Wook Kim;Yong-Hee Kim
    • Journal of Chest Surgery
    • /
    • 제57권3호
    • /
    • pp.323-327
    • /
    • 2024
  • This case report presents 2 patients with gastroesophageal junction cancer who both underwent totally minimally invasive esophagectomy with colon interposition. Patients 1 and 2, who were 43-year-old and 78-year-old men, respectively, had distinct clinical presentations and medical histories. Patient 1 underwent minimally invasive robotic esophagectomy with a laparoscopic total gastrectomy, colonic conduit preparation, and intrathoracic esophago-colono-jejunostomy. Patient 2 underwent completely robotic total gastrectomy, colon conduit preparation, and intrathoracic esophago-colono-jejunostomy. The primary challenge in colon interposition is assessing colon vascularity and ensuring an adequate conduit length, which is critical for successful anastomosis. In both cases, we used indocyanine green fluorescence angiography to evaluate vascularity. Determining the appropriate conduit is challenging; therefore, it is crucial to ensure a slightly longer conduit during reconstruction. Because totally minimally invasive colon interposition can reduce postoperative pain and enhance recovery, this surgical technique is feasible and beneficial.

Is Early Detection of Colon Cancer Possible with Red Blood Cell Distribution Width?

  • Ay, Serden;Eryilmaz, Mehmet Ali;Aksoy, Nergis;Okus, Ahmet;Unlu, Yasar;Sevinc, Baris
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권2호
    • /
    • pp.753-756
    • /
    • 2015
  • Background: Red cell distribution width (RDW) is one of the standard parameters with blood cell counts. Much previous research has indicated that it increases in cases of systemic inflammation or cardiametabolic incident. However, information on the relation of RDW with solid tumors causing systemic inflammation is limited. In the present research, we examined the relation of RDW with malignant and benign lesions of the colon. Materials and Methods: 115 patients with colon polyps (group 1), and 30 with colon cancer (group 2) who were diagnosed histopathologically in our clinic between January 2010-January 2013 were scanned retrospectively. Patients with anemia, hematologic diseases and active inflammation were excluded. RDW, mean corpuscular volume (MCV), hemoglobin (Hgb) and platelet (Plt) measurements were recorded and their relations with the malignant and benign lesions of the colon were examined. Results: Both groups were similar in age and gender distribution. RDW values of patients with colon cancer were significantly higher than the patients with colon polyp (p=0,01). No significant differences were detected between the two groups in terms of MCV and Plt values (p>0,05). Conclusions: RDW can be used as an early warning biomarker for solid colon tumors. Further prospective research is required on the relations of cheap and easily measured RDW parameters with colon malignancies.

S상 결장 분절확장증 (Segmental Dilatation of the Sigmoid Colon : A Rare Cause of Chronic Constipation)

  • 박우현;최순옥;백태원;이희정;서수지;김상표
    • Advances in pediatric surgery
    • /
    • 제1권1호
    • /
    • pp.68-72
    • /
    • 1995
  • Segmental dilatation of the colon is a very rare disease entity of unknown etiology and may mimic Hirschsprung's disease. It is characterized by dilatation of a segment of the colon of variable length with obstruction due to lack of peristalsis in a normally innervated intestine. Recently authors experienced a case of segmental dilatation of the sigmoid colon in a 6 month-old male, who presented with severe constipation, abdominal distention, and abdominal mass since 2 months of age. Down's syndrome and congenital nystagmus were associated. Barium enema demonstrated focal dilatation of the sigmoid colon, but the rectum and descending colon proximal t o the affected colon were of normal caliber. Rectal suction biopsy with acetylcholinesterase staining was normal and anorectal manometry showed normal rectosphincteric reflex. At operation, there was a massively dilated and hypertrophied sigmoid colon with increased tortuous serosal vessels, measuring 15 cm in length and 10 cm in width. Teniae coli were identifiable in the affected segment. Frozen section biopsies at the proximal, affected, and distal colon showed ganglion cells. Descending loop colostomy was constructed initially and segmental resection and end to end colocolostomy were carried out 3 months later. Final histologic examination showed 1) normal colonic mucosa with ganglion cells, 2) prominent submucosal fibrosis and marked muscular hypertrophy, 3) unremarkable acetylcholinesterase activity and immunohistochemical findings against S-100 protein. On 8 months follow-up, he has been doing well and moves bowels 1-2 times daily.

  • PDF

Association Between Survivin Gene Polymorphisms and the Susceptibility to Colon Cancer Development in the Turkish Population

  • Yamak, Nesibe;Yaykasli, Kursat Oguz;Yilmaz, Umit;Eroz, Recep;Uzunlar, Ali Kemal;Ankarali, Handan;Sahiner, Cem;Baltaci, Davut
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권20호
    • /
    • pp.8963-8967
    • /
    • 2014
  • Background: Colon cancer is one of the most common cancers worldwide. Apoptosis is a necessary physiological process for cell elimination which is very important both cellular homeostasis and cell proliferation and differantiation. Dysregulation can lead to uncontrolled cell growth and tumor development. Survivin, a member of the IAP family, plays a key role in promotion of cell proliferation as well as inhibition of apoptosis in cancer cells. The aim of this study was to investigate whether specific genetic polymorphisms of survivin could be associated with colon cancer development and progression in a Turkish population. Our study is the first to our knowledge to investigate the relationship between colon cancer risk and survivin gene polymorphisms. Materials and Methods: The relation between colon cancer and survivin -31 G/C (rs9904341), -241 C/T (rs17878467) and -625 C/G (rs8073069) polymorphism in promotor site of survivin gene associated with apoptosis was investigated using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results: Individuals with -31C allele and CC genotype were found to have a higher risk of developing colon cancer (OR=13.4, p=0.01). The -241 CT genotype considerably increased the risk of colon cancer (OR=12.0, p=0.0001). However, there was no significant varaition of the survivin -625 C/G polymorphism among colon cancer patients and controls in our study. Conclusions: This study provides the first evidence that survivin -31 G/C and -241 C/T SNP significantly contribute to the risk of colon cancer in the Turkish population.

hARIP2 is a Putative Growth-promoting Factor Involved in Human Colon Tumorigenesis

  • Gao, Rui-Feng;Li, Zhan-Dong;Jiang, Jing;Yang, Li-Hua;Zhu, Ke-Tong;Lin, Rui-Xin;Li, Hao;Zhao, Quan;Zhang, Nai-Sheng
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권20호
    • /
    • pp.8581-8586
    • /
    • 2014
  • Activin is a multifunctional growth and differentiation factor of the growth factor-beta (TGF-${\beta}$) superfamily, which inhibits the proliferation of colon cancer cells. It induces phosphorylation of intracellular signaling molecules (Smads) by interacting with its type I and type II receptors. Previous studies showed that human activin receptor-interacting protein 2 (hARIP2) can reduce activin signaling by interacting with activin type II receptors; however, the activity of hARIP2 in colon cancer has yet to be detailed. In vitro, overexpression of hARIP2 reduced activin-induced transcriptional activity and enhanced cell proliferation and colony formation in human colon cancer HCT8 cells and SW620 cells. Also, hARIP2 promoted colon cancer cell apoptosis, suggesting that a vital role in the initial stage of colon carcinogenesis. In vivo, immunohistochemistry revealed that hARIP2 was expressed more frequently and much more intensely in malignant colon tissues than in controls. These results indicate that hARIP2 is involved in human colon tumorigenesis and could be a predictive maker for colon carcinoma aggressiveness.

천추(天樞) 및 상거허(上巨虛)의 침자극(針刺棘)이 대장(大腸) 통과시간(通過時間)에 미치는 영향(影響) (The clinical study of colonic transit time stimulated manual acupuncture and electo-acupuncture(ST25, ST37))

  • 김동웅;이상용;이창현
    • Journal of Acupuncture Research
    • /
    • 제15권2호
    • /
    • pp.311-318
    • /
    • 1998
  • 목적: 현재 소화기 증상이 없고 정상적인 배변 양상과 습관을 갖고 있으며 과거력상 만성적인 소화기 계통의 질환이 없었던 정상 성인에게 대장운동과 관계있다고 알려진 천추와 상거허에 침자극하고 대장 통과시간의 변화를 관찰하고자 하였다. 방법: 정상 성인 11명의 침자극전 대장 통과시간을 방사선 비투과성 표지자인 Sitzmarks capsule을 사용하여 우측 및 좌측 대장과 직결장, 전대장 통과시간 등으로 나누어 측정한후 대장의 하합혈인 상거허와 복모혈인 천추에 단순유침 15분 및 전침으로 침자극하고 같은 방법으로 대장 통과시간을 측정하여 비교하였다. 결과: 침자극전의 대장 통과시간 측정은 전대장 통과시간이 $10.60{\pm}12.11$시간 이었으며 우측 및 좌측 대장과 직결장의 통과시간이 각각 $3.92{\pm}7.72,\;3.27{\pm}6.37,\;3.41{\pm}5.57$시간 이었다. 단순 15분 유침후 대장 통과시간의 측정은 전대장 통과시간이 $10.48{\pm}12.35$시간, 우측 및 좌측 대장과 직결장의 대장통과 시간이 각각 $3.72{\pm}7.52,\;3.37{\pm}6.76,\;3.39{\pm}5.84$ 시간으로 유의하지 않았다(P>0.05) 전침 자극후 대장 통과시간의 측정은 전대장 통과시간이 $10.30{\pm}13.21$, 우측 및 좌측 대장과 직결장의 통과 시간이 각각 $3.92{\pm}8.02,\;3.07{\pm}5.41,\;3.31{\pm}5.49$ 시간으로 좌측 대장 통과시간이 유의한(P<0.05) 단축 소견을 보였고 우측, 직결장의 통과시간은 유의하지 않았다(P>0.05). 결론: 본 연구의 결과로서 좌측 대장의 통과시간이 천추와 상거허에 전침 자극시 유의하게 단축되는 것을 확인 할 수 있었다. 이것은 전침이 신경계나 체액성 작용에 의해서 신경의 흥분성을 증가시켜 좌측 대장에서 직결장쪽으로 대장 내용물의 이동을 촉진하는 것으로 생각 할 수 있다. 그러나 단순 유침에서는 침자극전 대장 통과시간과 차이를 보이지 않음으로서 모든 침자극이 정상인의 대장운동이 변화를 일으키지는 않는 것으로 생각되었으며 더욱이 전침자극후 좌측 대장외에 우측 대장, 직결장은 단순 유침과 전침자극에 모두 변화가 없었고 전대장 통과 시간의 변화도 유의성이 없어 천추와 상거허의 침자극은 정상인의 대장운동에 영향을 주지는 않을 것으로 사려되었다.

  • PDF

동연동성 좌측결장을 이용한 식도재건술 (Esophageal Reconstruction with Isoperistaltic Interposition of Left Colon)

  • 성시찬
    • Journal of Chest Surgery
    • /
    • 제24권9호
    • /
    • pp.895-902
    • /
    • 1991
  • The surgical experience on 18 patients with benign or malignant stricture of the esophagus who underwent isoperistaltic interposition of left colon from April 1989 to July 1991 was reviewed. During same period 22 esophageal reconstructions with colon were performed, but 3 patients who had intraabdominal adhesion in the left upper quadrant and one patient who had uncertainty of blood supply of left colic artery could not undergo iso-peristaltic interposition of left colon. There were 12 male and 6 female patients ranging from 16 to 65 years of age. 12 patients had corrosive esophageal stricture, two had cancer of esophagus, and another two had hypopharyngeal cancer. The postoperative complications developed in 7 patients [38.8%] and most frequently encountered complication was cervical anastomotic leakage, which was successfully managed with simple drainage in all cases but one malignant patient. There was no operative mortality. The esophageal reconstruction with isoperistaltic left colon resulted in good function in 14 patients[77.8%], fair in 3 patients[16.7], and poor in 1 patient[5.6%]. In this experience esophageal reconstruction using isoperistaltic left colon is a satisfactory method that can be accomplished with acceptable morbidity and mortality.

  • PDF